Filing Details
- Accession Number:
- 0001209191-23-048905
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-11 13:52:12
- Reporting Period:
- 2023-09-07
- Accepted Time:
- 2023-09-11 13:52:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1515673 | Ultragenyx Pharmaceutical Inc. | RARE | Pharmaceutical Preparations (2834) | 272546083 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1603347 | Alan Theodore Huizenga | C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 | Svp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-07 | 2,000 | $21.00 | 25,777 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-09-07 | 2,000 | $41.00 | 23,777 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-09-07 | 163 | $38.34 | 23,614 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-09-07 | 2,000 | $0.00 | 2,000 | $21.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,000 | 2024-01-29 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
- Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.
- 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.
Billionaire Hedge Funds
